Latest Regulatory Approval News

Golden Horse Minerals updates its Southern Cross Project exploration with compelling soil geochemistry results revealing extensive gold anomalies and confirms acquisition of the Irene Betty lease, setting the stage for targeted drilling in 2025.

GTI Energy Ltd reports promising uranium leach test results from its Lo Herma project in Wyoming, demonstrating approximately 75% recovery rates consistent with regional ISR operations. These findings underpin the upcoming Scoping Study expected in H1 2025.

E79 Gold Mines has identified promising new drill targets at its Laverton South Project following significant gold mineralisation results from neighbouring Kalgoorlie Gold Mining Ltd. The company plans to initiate aircore drilling in the March Quarter to test these high-potential zones.

CSL Limited reported a solid half-year performance with 5% revenue growth and a 7% rise in net profit, driven by strong demand in its Behring and Vifor segments despite challenges in Seqirus. The company reaffirmed its full-year NPATA guidance of 10-13%, signaling confidence in its operational momentum.

Mantle Minerals Limited has announced a significant 10-for-1 consolidation of its ordinary shares and performance rights, set to reshape its capital structure by March 2025. This move aims to streamline the company’s share register ahead of renewed market activity.

Foresta Group Holdings has signed a non-binding term sheet with Genesis Energy to supply torrefied wood pellets for Huntly Power Station, marking a pivotal step toward reducing New Zealand’s coal dependency by 2028.

Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.

TEAMINVEST PRIVATE GROUP LIMITED has announced a fully franked ordinary dividend of AUD 0.015 per share for the six months ending December 31, 2024, payable in March 2025.

Wellnex Life Limited has announced a non-renounceable entitlement offer to raise approximately $22.1 million at $0.65 per share, supporting its planned AIM listing and strategic growth initiatives.

Wellnex Life Limited has initiated a $22.1 million entitlement offer priced at $0.65 per share, coinciding with its proposed dual listing on the London Stock Exchange's AIM market, driven by strong UK institutional interest.

BTC Health has transformed its decade-long license agreement with Arna Pharma into an indefinite partnership, gaining royalties from Singapore and Malaysia sales and first rights to new pharmaceutical products in Australia and New Zealand.

S2 Resources has initiated its first aircore drilling campaign at the Yeungroon project, aiming to delineate gold-arsenic hotspots along the extensive O'Connors trend. Results are expected by April 2025, potentially unlocking new opportunities in Victoria’s historic goldfields.